Holdings

Sphera Funds Management LTD.

As of Sep 30, 2026, Sphera Funds Management LTD. reported 89 positions worth US$547M. Largest: Mineralys Therapeutics, Inc., Alnylam Pharmaceuticals, Inc. and Cytokinetics, Incorporated. What it bought and sold, with each filing.

CompanySharesValue as reportedChangeAs of
Mineralys Therapeutics, Inc.1.32MUS$33.2M−148KSep 30, 2026
Alnylam Pharmaceuticals, Inc.121KUS$29.8M+110KSep 30, 2026
Cytokinetics, Incorporated362KUS$23.9M+142KSep 30, 2026
iShares Semiconductor ETF37,000US$21MnewSep 30, 2026
BridgeBio Pharma, Inc.312KUS$20.5M+66,371Sep 30, 2026
Syndax Pharmaceuticals, Inc.1.01MUS$18.9M−7,328Sep 30, 2026
BioMarin Pharmaceutical Inc.293KUS$17.6M−35,304Sep 30, 2026
Biogen Inc.75,763US$17.1M−20,863Sep 30, 2026
Cogent Biosciences, Inc.502KUS$16.1M+42,200Sep 30, 2026
Madrigal Pharmaceuticals, Inc.25,795US$13M+8,376Sep 30, 2026